Critical hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. No antihypertensive drugs were taken in the past 4 weeks and the upper brachial artery sitting blood pressure, systolic blood pressure (SBP) of 120-139mmHg and/or diastolic blood pressure (DBP) of 80-89mmHg were measured for 3 consecutive times on different days within 1 week; 2. HAMA scores >= 14 and <= 29; 3. Aged 18-50 years, gender unlimited; 4. It meets the diagnostic criteria of liver depression and spleen deficiency; 5. Volunteer to participate and cooperate with the researcher by signing a written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with definite primary and secondary hypertension; 2. Borderline hypertension patients taking Western antihypertensive drugs; 3. Patients with acute or severe cerebrovascular diseases such as cerebral hemorrhage, subarachnoid hemorrhage, cerebral infarction and transient ischemic attack; 4. Patients with acute coronary syndrome, acute onset of chronic heart failure, malignant arrhythmia, valvular heart disease, cardiomyopathy and other serious cardiovascular diseases; 5. Pregnant and lactating women; 6. Patients with severe liver and kidney dysfunction who were determined by the researchers not to be included in the group; 7. Patients who have taken anti-anxiety medication in the last six months; 8. Patients with language or mental disorders, mental illness and other patients can not accurately describe their symptoms and understand the content of the questionnaire; 9. Patients with other bleeding diseases or intolerance to acupuncture.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immediate blood pressure before and after acupuncture; | — |
Secondary
| Measure | Time frame |
|---|---|
| Ambulatory blood pressure Mean blood pressure;TCM syndrome score;Serum HYC, CRP, TG, TC, HDL, LDL, PRA, ALD levels;The serum levels of nitric oxide(NO), superoxide dismutase (SOD), angiotensinII(AngII),calmodulin(CaM),hippocampal monoamine transmitter 5-hydroxytryptamine(5-HT) and dopamine(DA);Changes in the contents of NF-kB, Myd88, TLR4, IL-6, TNF-a, NLRP3, SIRT1, IL-1ß and IL-18 in venous blood; | — |
Countries
China
Contacts
Guang'anmen Hospital, China Academy of Chinese Medical Sciences